Jacobson ME, Myles IA, Paller AS, Eichenfield LF, et al. A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 16-Week Trial to Evaluate the Efficacy and Safety of FB-401 in Children, Adolescent and Adult Subjects (Ages 2 Years and Older) with Mild to Moderate Atopic Dermatitis. Dermatology 2023 Aug 14. doi: 10.1159/000532054.
PMID: 37579728